Thermo Fisher's Oncomine Dx test gets FDA nod as CDx for cancer drug
Thermo Fisher Scientific CE Marks Oncomine Dx Target Test | Technology Networks
Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies | Today's Clinical Lab
Thermo Fisher's Oncomine Dx approved in US to identify NSCLC patients
Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software to Expand Access to Precision Oncology Biomarker Testing